L306-1805 Screening compound: N-(5-methylpyridin-2-yl)-1-[(2-oxo-3-propyl-2,3-dihydro-1,3-benzothiazol-6-yl)sulfonyl]piperidine-4-carboxamide

L306-1805 Screening compound: N-(5-methylpyridin-2-yl)-1-[(2-oxo-3-propyl-2,3-dihydro-1,3-benzothiazol-6-yl)sulfonyl]piperidine-4-carboxamide
L306-1805 Screening compound: N-(5-methylpyridin-2-yl)-1-[(2-oxo-3-propyl-2,3-dihydro-1,3-benzothiazol-6-yl)sulfonyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L306-1805
N-(5-methylpyridin-2-yl)-1-[(2-oxo-3-propyl-2,3-dihydro-1,3-benzothiazol-6-yl)sulfonyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L306-1805

Molecular Formula

C22H26N4O4S2 (C22 H26 N4 O4 S2)

Compound Name

N-(5-methylpyridin-2-yl)-1-[(2-oxo-3-propyl-2,3-dihydro-1,3-benzothiazol-6-yl)sulfonyl]piperidine-4-carboxamide

IUPAC name

N-(5-methylpyridin-2-yl)-1-[(2-oxo-3-propyl-23-dihydro-13-benzothiazol-6-yl)sulfonyl]piperidine-4-carboxamide

SMILES

CCCN(c(ccc(S(N(CC1)CCC1C(Nc1ncc(C)cc1)=O)(=O)=O)c1)c1S1)C1=O

InChI

InChI=1S/C22H26N4O4S2/c1-3-10-26-18-6-5-17(13-19(18)31-22(26)28)32(29,30)25-11-8-16(9-12-25)21(27)24-20-7-4-15(2)14-23-20/h4-7,13-14,16H,3,8-12H2,1-2H3,(H,23,24,27)

InChI Key

GMHUUHYJKFWYGA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27243578

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

474.61

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.128

Distribution Coefficient, logD

4.126

Water Solubility, LogSw

-4.01

Polar Surface Area

80.568

Acid Dissociation Constant (pKa)

10.05

Base Dissociation Constant (pKb)

4.61

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.90

L306-1805 in Drug Discovery

Included in Screening Libraries

Macl-GPIb alpha Interaction Library (22969 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L306-1805 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L306-1805?
Check Price and Availability of L306-1805, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L306-1805 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L306-1805
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L306-1805
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L306-1805 available by request